TABLE 3.

Patient characteristics—MBL2 genotypes^*

Variable	C/C (n = 188)	C/G (n = 87)	G/G (n = 20)
age >75 yrs†	31.4%	26.4%	5.0%
yrs of education (mean)	14.7 ± 3.1	14.4 ± 3.6	13.9 ± 2.0
BMI (mean)	26.8 ± 4.5	27.9 ± 5.1	27.8 ± 4.0
history of smoking	72.9%	71.3%	75.0%
hypertension	60.6%	49.4%	60.0%
statin use†	75.5%	74.7%	50.0%
diabetes mellitus	21.8%	20.7%	25.0%
PVD	28.7%	28.7%	10.0%
symptomatic‡	49.5%	39.1%	40.0%
cross-clamp duration in minutes (mean)	46.0 ± 18.2	45.7 ± 16.6	46.6 ± 18.6
CD at 1 day after CEA	19.1%	17.2%	45.0%
CD at 1 month after CEA	12.2%	15.4%	16.7%
white	91.5%	88.5%	95.0%
black	2.7%	4.6%	5.0%
Hispanic	1.6%	2.3%	0%
other	4.3%	4.6%	0%

^*Values represent percentages of patients unless otherwise indicated. Means are given with SDs.

^†Significant association with SNP genotype (p < 0.05).

^‡Due to previous cerebrovascular accident, stroke, or transient ischemic attack.